19
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington's disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Huntington's Disease (HD) is a neurodegenerative disease caused by poly-glutamine expansion in the Htt protein, resulting in Htt misfolding and cell death. Expression of the cellular protein folding and pro-survival machinery by heat shock transcription factor 1 (HSF1) ameliorates biochemical and neurobiological defects caused by protein misfolding. We report that HSF1 is degraded in cells and mice expressing mutant Htt, in medium spiny neurons derived from human HD iPSCs and in brain samples from patients with HD. Mutant Htt increases CK2α′ kinase and Fbxw7 E3 ligase levels, phosphorylating HSF1 and promoting its proteasomal degradation. An HD mouse model heterozygous for CK2α′ shows increased HSF1 and chaperone levels, maintenance of striatal excitatory synapses, clearance of Htt aggregates and preserves body mass compared with HD mice homozygous for CK2α′. These results reveal a pathway that could be modulated to prevent neuronal dysfunction and muscle wasting caused by protein misfolding in HD.

          Abstract

          Huntington's disease (HD) is caused by misfolding of mutant Htt protein. The authors find that in HD models, the decreased expression of heat shock transcription factor 1 that usually protects against protein misfolding, is in part caused by elevated CK2α' kinase and Fbxw7 E3 ligase expression.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          Molecular chaperones in protein folding and proteostasis.

          Most proteins must fold into defined three-dimensional structures to gain functional activity. But in the cellular environment, newly synthesized proteins are at great risk of aberrant folding and aggregation, potentially forming toxic species. To avoid these dangers, cells invest in a complex network of molecular chaperones, which use ingenious mechanisms to prevent aggregation and promote efficient folding. Because protein molecules are highly dynamic, constant chaperone surveillance is required to ensure protein homeostasis (proteostasis). Recent advances suggest that an age-related decline in proteostasis capacity allows the manifestation of various protein-aggregation diseases, including Alzheimer's disease and Parkinson's disease. Interventions in these and numerous other pathological states may spring from a detailed understanding of the pathways underlying proteome maintenance.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Heat shock factors: integrators of cell stress, development and lifespan.

            Heat shock factors (HSFs) are essential for all organisms to survive exposures to acute stress. They are best known as inducible transcriptional regulators of genes encoding molecular chaperones and other stress proteins. Four members of the HSF family are also important for normal development and lifespan-enhancing pathways, and the repertoire of HSF targets has thus expanded well beyond the heat shock genes. These unexpected observations have uncovered complex layers of post-translational regulation of HSFs that integrate the metabolic state of the cell with stress biology, and in doing so control fundamental aspects of the health of the proteome and ageing.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.

              Protein kinase CK2 ('casein kinase II') has traditionally been classified as a messenger-independent protein serine/threonine kinase that is typically found in tetrameric complexes consisting of two catalytic (alpha and/or alpha') subunits and two regulatory beta subunits. Accumulated biochemical and genetic evidence indicates that CK2 has a vast array of candidate physiological targets and participates in a complex series of cellular functions, including the maintenance of cell viability. This review summarizes current knowledge of the structural and enzymic features of CK2, and discusses advances that challenge traditional views of this enzyme. For example, the recent demonstrations that individual CK2 subunits exist outside tetrameric complexes and that CK2 displays dual-specificity kinase activity raises new prospects for the precise elucidation of its regulation and cellular functions. This review also discusses a number of the mechanisms that contribute to the regulation of CK2 in cells, and will highlight emerging insights into the role of CK2 in cellular decisions of life and death. In this latter respect, recent evidence suggests that CK2 can exert an anti-apoptotic role by protecting regulatory proteins from caspase-mediated degradation. The mechanistic basis of the observation that CK2 is essential for viability may reside in part in this ability to protect cellular proteins from caspase action. Furthermore, this anti-apoptotic function of CK2 may contribute to its ability to participate in transformation and tumorigenesis.
                Bookmark

                Author and article information

                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group
                2041-1723
                13 February 2017
                2017
                : 8
                : 14405
                Affiliations
                [1 ]Department of Pharmacology and Cancer Biology, Duke University School of Medicine , Durham, North Carolina 27710, USA
                [2 ]Department of Biochemistry, Duke University School of Medicine , Durham, North Carolina 27710, USA
                [3 ]Departament de Ciencies Mediques Basiques, IRB Lleida, Universitat de Lleida , Lleida 25008, Spain
                [4 ]Department of Cell Biology, Duke University School of Medicine , Durham, North Carolina 27710, USA
                [5 ]Department of Molecular Genetics and Microbiology, Duke University School of Medicine , Durham, North Carolina 27710, USA
                [6 ]Department of Neurobiology, Duke University School of Medicine , Durham, North Carolina 27710, USA
                [7 ]Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine , Baltimore, Maryland 21205, USA
                [8 ]Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, Maryland 21205, USA
                [9 ]Department of Pharmacology, Johns Hopkins University School of Medicine , Baltimore, Maryland 21205, USA
                [10 ]Department of Neuroscience, Johns Hopkins University School of Medicine , Baltimore, Maryland 21205, USA
                Author notes
                Author information
                http://orcid.org/0000-0002-3704-8919
                Article
                ncomms14405
                10.1038/ncomms14405
                5316841
                28194040
                8c4f621e-5e77-4c52-a1bc-30ac16e5794c
                Copyright © 2017, The Author(s)

                This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

                History
                : 03 May 2016
                : 21 December 2016
                Categories
                Article

                Uncategorized
                Uncategorized

                Comments

                Comment on this article